Echo Therapeutics Announces Closing of Approximately $2.3 Million ... - PR Newswire (press release)
Durhalieve(TM), Echo's lead AzoneTS drug candidate, is an advanced topical reformulation of triamcinolone acetonide for treatment of corticosteroid ...